Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCCP, MRCP (UK), DTCD, MCPS
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, M.D (Medicine), M.D Nephrology (Gold Medlist), ESENeph
Internal Medicine Specialist
MBBS, M.D (Medicine), M.D Nephrology (Gold Medlist), ESENeph
Consultant Physician
M.B.B.S., M.C.P.S
Rheumatologist
MBBS, FCPS (Medicine), Fellowship in Rheumatology
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, MCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures